Financials
- Market Capitalization 2.15 B
- Employee 361
- Founded 2016
- CEO N/A
- Website www.veratx.com
- Headquarter Delaware, United States
- FIGI BBG00Q72WYG3
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-10.87
Fiyat/satışlar oranı
7 992.14
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1887 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.65 USD | +2.65% | +5.65% | +3.16% | +39.56% | 2.22 B USD | ||
| 1893 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.55 USD | +3.14% | +4.65% | +4.65% | +18.26% | 2.18 B USD | ||
| 1916 | VRDN Viridian Therapeutics, Inc. - Common Stock | 18.66 USD | +1.74% | -3.86% | -13.09% | -16.88% | 2.11 B USD | ||
| 1920 | NVAX Novavax, Inc. - Common Stock | 12.75 USD | +15.80% | +21.78% | +35.35% | +51.43% | 2.10 B USD |